The government expert panel has recommended approval for Covishield and Covaxin in regular markets!
Written by Shivangi chawla
As the Coronavirus cases are rising rapidly in the world. Many rules and regulations are imposed in the nation. Social distancing, wearing masks are the basic protocols that are crucial for every individual to save their and others’ lives too. Vaccination is a must for every person starting from teens to the old age groups. Many people are still resisting getting vaccines jabs.
However, Government is trying its level best to reach every individual to vaccinate them. Earlier, there were many restrictions on the use of the covid vaccines but now after completing 3 successful trials, vaccines are considered safe and are also permitted to be available as a new drug store with conditions for the adult population.
A full market authorization is granted when a vaccine is deemed safe and effective for most people who are inoculated with it. Such approval is authorized after submission and review of full data from phase 1, 2, and 3 trials of the jab. Currently, Covid vaccines are not available in the open retail market in any country. Covishield and Covaxin are currently only authorized for emergency use in India.
In October 2021, pharma companies Serum Institute of India (SII) and Bharat Biotech had submitted applications to the Drugs Controller General of India (DCGI) seeking regular market authorization for their respective Covid-19 vaccines Covishield and Covaxin. Subject Expert Committee of Central Drugs Standard Control Organisation has made the recommendation for regular market approval of the two jab